1 domain / 2 areas / 1 specialization
The Washington Post
Data updated
Major U.S. news publication with ongoing reporting on psychedelic health research, therapeutic access, legal frameworks, and safety concerns.
Media & Communication Snapshot
General Media OutletsCadence
Daily
Access
Subscription
Psychedelic Focus
Psychedelic-Adjacent Focus
Verification
Verified
Audience
Coverage Focus
Media Notes
The Washington Post is a major US daily newspaper covering national politics, health and science. Its psychedelic coverage sits within general health and politics reporting, including explainers on psilocybin and MDMA therapy and news and opinion pieces on the 2026 US executive order fast-tracking psychedelic research. Most content sits behind a metered paywall.
Source Evidence
The Washington Post
https://www.washingtonpost.com/
Psilocybin as a mental health therapy? Some things to know
https://www.washingtonpost.com/health/2022/09/05/psilocybin-mental-health-psychedelics/
Trump orders more access to psychedelics like psilocybin, ibogaine
https://www.washingtonpost.com/politics/2026/04/17/trump-psychedelics-psylocibin-research/
Quick Facts
- Type
- Other
- HQ
- United States
- Website
- Visit